| 标题 |
Dose Optimization to Mitigate the Risk of CRS with Elranatamab in Multiple Myeloma |
| 网址 | |
| DOI |
10.1182/blood-2022-169971
doi
|
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)